Stock FREDUN6 FREDUN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Fredun Pharmaceuticals Limited

Equities

FREDUN6

INE194R01017

Market Closed - Bombay S.E.
Other stock markets
 03:30:58 14/06/2024 pm IST 		5-day change 1st Jan Change
933.4 INR +1.66% Intraday chart for Fredun Pharmaceuticals Limited +14.83% +7.44%
10/05 Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 CI
08/05 Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24
CI
Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9%
MT
Fredun Pharmaceuticals Limited Plans to Put a New Facility for Production of Functional Foods for its Veterinary Segment
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Fredun Pharmaceuticals Secures Orders from Sea Countries, Expands Product Development in Veterinary Care, and Advances Orthopaedic Applications
CI
Fredun Pharmaceuticals Limited Announces Appointment of Ms. Daisy Cyril Dsouza as Additional Independent Director
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Fredun Pharmaceuticals Limited Declared A Dividend At 7% on the Equity Shares of the Company for the Financial Year Ended March 31, 2023
CI
Fredun Pharmaceuticals Limited Proposes Dividend for the Financial Year Ended March 31, 2023
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Fredun Pharmaceuticals Limited Approves the Resignation of Dr. Chandrakant Shah as Independent Director
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Fredun Pharmaceuticals Limited announced that it has received INR 275.691377 million in funding
CI
Fredun Pharmaceuticals Limited Announces Change in Registered Office Address
CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022
CI
Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FREDUN6 Stock
  4. News Fredun Pharmaceuticals Limited